How BRCA1 downregulation is mediated has remained unclear in this case, but the tyrosine kinase activity of BCR-ABL1 is therefore of importance, similar to what has been observed for DNA-PK decrease in CML [114]. This evidence concerns the gene PRKDC and chronic myelogenous leukemia, BCR-ABL1 positive.